.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Teva
Chubb
Covington
Citi
Fish and Richardson
AstraZeneca
Julphar
Farmers Insurance

Generated: September 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: simvastatin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
14599AII11/29/1999TEVA PHARMACEUTICAL INDUSTRIES LTDSIMVASTATIN
15722III11/7/2001SUN PHARMACEUTICAL INDUSTRIES LTDSIMVASTATIN USP
16094AII8/12/2002BIOCON LTDSIMVASTATIN USP
16305AII12/11/2002ZHEJIANG HISUN PHARMACEUTICAL CO LTDSIMVASTATIN USP
17151III2/10/2004KREBS BIOCHEMICALS INDUSTRIES LTDSIMVASTATIN USP
17568III7/27/2004LEK PHARMACEUTICALS DDSIMVASTATIN
17829AII11/8/2004AUROBINDO PHARMA LTDSIMVASTATIN USP
17934AII12/27/2004LUPIN LTDSIMVASTATIN USP
17959III12/30/2004GLENMARK PHARMACEUTICALS LTDSIMVASTATIN
18101III1/25/2005ZHEJIANG RUIBANG LABORATORIES INCSIMVASTATIN USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Deloitte
AstraZeneca
Healthtrust
Cipla
US Department of Justice
Johnson and Johnson
Mallinckrodt
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot